Antibodies (therapeutic use)

Recombinant bispecific antibodies for cancer therapy.
[15659107] Acta Pharmacol Sin 26(1): 1-9 (2005)

Immunotoxicity of monoclonal antibodies.
[20061816] MAbs 1(2): 104-11 (2009)

Engineered CH2 domains (nanoantibodies).
[20046570] MAbs 1(1): 26-8 (2009)

The use of monoclonal antibody conjugates for the diagnosis and treatment of cancer.
[3301638] Immunol Cell Biol 65 ( Pt 2)(-): 111-25 (1987)

Immunotoxins and cancer therapy.
[16191416] Cell Mol Immunol 2(2): 106-12 (2005)

Monoclonal antibodies as therapeutic agents in oncology and antibody gene therapy.
[17242688] Cell Res 17(2): 89-99 (2007)

Antibody engineering to develop new antirheumatic therapies.
[19490600] Arthritis Res Ther 11(3): 225 (2009)

Combination antibody-based cancer immunotherapy.
[17559424] Cancer Sci 98(9): 1297-302 (2007)

New approaches to antibody therapy.
[11156528] Oncogene 19(53): 6144-51 (2000)

From bench to bedside: discovering rules for antibody design, and improving serotherapy with monoclonal antibodies.
[11477276] Rheumatology (Oxford) 40(7): 724-38 (2001)

The advantage of protecting the antigen-binding site during antibody labeling.
[1988615] J Nucl Med 32(1): 122-3 (1991)

New antibody conjugates in cancer therapy.
[20953556] ScientificWorldJournal 10(-): 2070-89 (2010)

The next generation of antibody-drug conjugates comes of age.
[21034674] Discov Med 10(53): 329-39 (2010)

Therapeutic antibodies: successes, limitations and hopes for the future.
[19459844] Br J Pharmacol 157(2): 220-33 (2009)

Immunotherapy of malignant disease with tumor antigen-specific monoclonal antibodies.
[20028761] Clin Cancer Res 16(1): 11-20 (2010)

Radionuclide-antibody conjugates for single-cell cytotoxicity.
[11877748] Cancer 94(4 Suppl): 1215-23 (2002)

Choosing an optimal radioimmunotherapy dose for clinical response.
[11877757] Cancer 94(4 Suppl): 1275-86 (2002)

The state of the art: immune-mediated mechanisms of monoclonal antibodies in cancer therapy.
[19809433] Br J Cancer 101(11): 1807-12 (2009)

Oxidative stress by targeted agents promotes cytotoxicity in hematologic malignancies.
[19018667] Antioxid Redox Signal 11(5): 1123-37 (2009)

Advances in cancer therapy with radiolabeled monoclonal antibodies.
[17043623] Q J Nucl Med Mol Imaging 50(4): 248-64 (2006)

A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words.
[15640788] Q J Nucl Med Mol Imaging 48(4): 251-7 (2004)

Design and manufacture of monoclonal antibodies for radioimmunotherapy.
[15640789] Q J Nucl Med Mol Imaging 48(4): 258-66 (2004)

Engineered single chain antibody fragments for radioimmunotherapy.
[15640791] Q J Nucl Med Mol Imaging 48(4): 279-88 (2004)

Radioimmunotherapy of prostate cancer.
[15640793] Q J Nucl Med Mol Imaging 48(4): 297-304 (2004)

Immunotoxins and other conjugates containing saporin-s6 for cancer therapy.
[22069735] Toxins (Basel) 3(6): 697-720 (2011)

Toxin-based therapeutic approaches.
[22069564] Toxins (Basel) 2(11): 2519-83 (2010)

Targeted toxins in brain tumor therapy.
[22069569] Toxins (Basel) 2(11): 2645-62 (2010)

Antibody-based therapeutics to watch in 2011.
[21051951] MAbs 3(1): 76-99 (2011)

Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrier.
[21150307] MAbs 3(2): 153-60 (2011)

Engineering the variable region of therapeutic IgG antibodies.
[21406966] MAbs 3(3): 243-52 (2011)

Bridging the gap: facilities and technologies for development of early stage therapeutic mAb candidates.
[21822050] MAbs 3(5): 440-52 (2011)

Therapeutic antibodies directed at G protein-coupled receptors.
[20864805] MAbs 2(6): 594-606 (2010)

Metrics for antibody therapeutics development.
[20930555] MAbs 2(6): 695-700 (2010)

Have we overestimated the benefit of human(ized) antibodies?
[20935511] MAbs 2(6): 682-94 (2010)

Therapeutic antibodies in ophthalmology: old is new again.
[21358858] MAbs 2(2): 176-80 (2010)

Stability of IgG isotypes in serum.
[20404539] MAbs 2(3): 221-32 (2010)

Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies.
[20421713] MAbs 2(3): 233-55 (2010)

Antibody drug-conjugates targeting the tumor vasculature: Current and future developments.
[20069754] MAbs 1(3): 247-53 (2009)

Bispecific antibodies for cancer therapy: the light at the end of the tunnel?
[20073127] MAbs 1(6): 539-47 (2009)

Sensitivity and resistance to EGF-R inhibitors: approaches to enhance the efficacy of EGF-R antibodies.
[20068398] MAbs 1(6): 590-9 (2009)

Antibody-maytansinoid conjugates for the treatment of myeloma.
[20068397] MAbs 1(6): 548-51 (2009)

Americas Antibody Congress: September 21-23, 2009, Washington, D.C.
[20068395] MAbs 1(6): 523-30 (2009)

Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape.
[20697078] J Clin Oncol 28(28): 4390-9 (2010)

Monoclonal antibodies for cancer immunotherapy.
[19304016] Lancet 373(9668): 1033-40 (2009)

Therapeutic monoclonal antibodies.
[21720199] Keio J Med 60(2): 37-46 (2011)

Integrin targeted delivery of chemotherapeutics.
[21547159] Theranostics 1(-): 189-200 (2011)

Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.
[19529959] Med Microbiol Immunol 198(3): 157-74 (2009)

Invited article: human natural autoantibodies in the treatment of neurologic disease.
[19349608] Neurology 72(14): 1269-76 (2009)

One target, different effects: a comparison of distinct therapeutic antibodies against the same targets.
[21811090] Exp Mol Med 43(10): 539-49 (2011)

Non-fucosylated therapeutic antibodies: the next generation of therapeutic antibodies.
[19003000] Cytotechnology 55(2-3): 109-14 (2007)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Antibodies (therapeutic use).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Antibodies (therapeutic use).php on line 92